SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

RIZZI, Anna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.365
EU - Europa 1.867
AS - Asia 1.458
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
SA - Sud America 3
Totale 11.699
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.323
CN - Cina 728
UA - Ucraina 492
DE - Germania 444
SG - Singapore 396
TR - Turchia 302
GB - Regno Unito 269
IT - Italia 261
FI - Finlandia 171
SE - Svezia 91
CA - Canada 42
BE - Belgio 38
RU - Federazione Russa 31
FR - Francia 21
LT - Lituania 14
CZ - Repubblica Ceca 10
IN - India 10
IR - Iran 7
NL - Olanda 7
HK - Hong Kong 5
PL - Polonia 5
A2 - ???statistics.table.value.countryCode.A2??? 3
HR - Croazia 3
NO - Norvegia 3
BR - Brasile 2
ES - Italia 2
GR - Grecia 2
ID - Indonesia 2
JP - Giappone 2
NZ - Nuova Zelanda 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BD - Bangladesh 1
BG - Bulgaria 1
CL - Cile 1
DK - Danimarca 1
IQ - Iraq 1
KW - Kuwait 1
NP - Nepal 1
RO - Romania 1
UZ - Uzbekistan 1
Totale 11.699
Salva come PNG Salva come JPEG
Città #
Fairfield 1.156
Woodbridge 1.108
Houston 656
Jacksonville 574
Ann Arbor 564
Ashburn 546
Chandler 513
Seattle 435
Wilmington 409
Cambridge 379
Santa Clara 373
Singapore 332
Izmir 185
Nanjing 154
Beijing 144
Princeton 113
Milan 106
San Diego 101
Boardman 100
Shanghai 86
New York 74
Helsinki 66
Nanchang 60
Ferrara 58
Dearborn 54
Shenyang 47
Los Angeles 43
Munich 40
Brussels 37
Hebei 35
Bremen 34
London 26
Auburn Hills 25
Jiaxing 24
Mountain View 24
San Mateo 24
Falls Church 22
Mcallen 22
Norwalk 21
Tianjin 21
Changsha 19
Jinan 17
Montréal 17
Addison 16
Philadelphia 16
Zhengzhou 16
Redwood City 15
Toronto 15
Kunming 13
Tappahannock 13
Indiana 12
Falkenstein 10
Ningbo 10
Washington 9
Orange 8
Verona 8
Bologna 7
Düsseldorf 7
Frankfurt am Main 7
Guangzhou 7
Lanzhou 7
Ottawa 7
Des Moines 6
Hounslow 5
Olomouc 5
Redmond 5
Warsaw 5
Ardabil 4
Augusta 4
Brno 4
Fuzhou 4
Hong Kong 4
Monmouth Junction 4
Bari 3
Changchun 3
Clifton 3
Edinburgh 3
Ferrara di Monte Baldo 3
Hangzhou 3
Hefei 3
Leawood 3
Prescot 3
San Francisco 3
Taizhou 3
Zagreb 3
Auckland 2
Bondeno 2
Bonn 2
Boston 2
Chicago 2
Chiswick 2
Gattico 2
Islington 2
Jakarta 2
Juiz De Fora 2
La Canada Flintridge 2
Leicester 2
New Bedfont 2
Newark 2
Oderzo 2
Totale 9.163
Salva come PNG Salva come JPEG
Nome #
Characterization of FR 172357, a new non-peptide bradykinin B2 receptor antagonist, in human, pig and rabbit preparations 175
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 171
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 168
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. 155
Kinin B-1 and B-2 receptors in pig vessels: characterization of two monoreceptor systems 154
Human vascular kinin receptors of the B-2 type characterized by radioligand binding 153
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 149
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 148
A new selective antagonist of the nociceptin receptor 147
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 145
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 143
Pharmacological characterization of nociceptin receptor: an in vitro study 138
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 137
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 137
A new ligand for the urotensin II receptor 136
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 135
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 135
Effects of vasoactive agents in healthy and diseased human saphenous veins 133
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 131
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 130
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 129
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 129
Ala scan analogues of HOE 140. Synthesis and biological activities 129
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 125
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 124
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 124
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 124
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 123
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 123
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. 123
Pharmacological characterization of tachykinin tetrabranched derivatives 121
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists. 120
Nociceptin/orphanin FQ receptor knockout rats: in vitro and in vivo studies. 119
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 118
Structure-activity study at positions 3 and 4 of human neuropeptide S. 118
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 117
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 116
In vitro and in vivo pharmacological characterization of Pronetupitant, a prodrug of the neurokinin 1 receptor antagonist Netupitant 115
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 115
Urotensin II stimulates plasma extravasation in mice via UT receptor activation 115
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 114
Nociceptin receptor activation inhibits tachykinergic non adrenergic non cholinergic contraction of guinea pig isolated bronchus 114
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 112
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 111
B1 and B2 kinin receptors in various species 111
Effects of human urotensin II in isolated vessels of various species; comparison with other vasoactive agents 111
In vitro and in vivo pharmacological characterization of the novel NK(1) receptor selective antagonist Netupitant. 111
In vitro functional characterization of novel nociceptin/orphanin FQ receptor agonists in recombinant and native preparations 111
null 110
Structure-activity relationships of nociceptin and related peptides: comparison with dynorphin A 109
Pharmacological characterisation of novel kinin B2 receptor ligands 109
Altered anxiety-related behavior in nociceptin/orphanin FQ receptor gene knockout mice 109
Further studies at neuropeptide s position 5: discovery of novel neuropeptide S receptor antagonists. 109
Bradykinin receptors and receptor ligands (with special emphasis on vascular receptors) 108
The nociceptin/orphanin FQ receptor antagonist, [Nphe(1)]NC(1-13)NH2, potentiates morphine analgesia 108
Characterization of endothelin receptors in the human umbilical artery and vein 108
Pharmacological characterisation of the first non-peptide bradykinin B2 receptor agonist FR 190997: An in vitro study on human, rabbit and pig vascular B2 receptors 108
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl] methyl]-6,7,8,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vitro studies 108
Characterization of [Nphe(1)]nociceptin(1-13)NH2, a new selective nociceptin receptor antagonist 108
Pharmacology of the Kallikrein-Kinin system 107
UFP-101, a peptide antagonist selective for the nociceptin/orphanin FQ receptor 106
Peptide welding technology – A simple strategy for generating innovative ligands for G protein coupled receptors 106
null 105
The mouse vas deferens: A pharmacological preparation sensitive to nociceptin 105
Structure-activity relationship study on human urotensin II 104
Nociceptin receptor binding in mouse forebrain membranes: Thermodynamic characteristics and structure activity relationships 102
Anxiolytic-like effect of neuropeptide S in the rat defensive burying. 102
Receptors for kinins in the human isolated umbilical vein. 101
In vitro and in vivo pharmacological characterization of the nociceptin/orphanin FQ receptor ligand Ac-RYYRIK-ol 101
Neurobiology, pharmacology, and medicinal chemistry of neuropeptide S and its receptor 99
Nociceptin/orphanin FQ receptor ligands, 99
Effects of naloxone benzoylhydrazone on native and recombinant nociceptin/orphanin FQ receptors 98
Structure-activity studies of the Phe(4) residue of nociceptin(1-13)-NH2: Identification of highly potent agonists of the nociceptin/orphanin FQ receptor 98
Antinociceptive action of NOP and opioid receptor agonists in the mouse orofacial formalin test 97
Spinal antinociceptive effects of the novel NOP receptor agonist PWT2-nociceptin/orphanin FQ in mice and monkeys 97
Pharmacological characterization of a vasopressin V1 receptor in the isolated human gastric artery 96
Contractile activity of endothelins and their precursors in human umbilical artery and vein: identification of distinct endothelin-converting enzyme activities 95
Endogenous nociceptin signaling and stress-induced analgesia 94
Pharmacology of [tyr1]nociceptin analogs: receptor binding and bioassay studies 93
FR 173657: a new, potent, nonpeptide kinin B2 receptor antagonist. An in vitro study 93
Pharmacology of nociceptin and its receptor: a novel therapeutic target 92
Pharmacological characterization of the nociceptin/orphanin FQ receptor antagonist SB-612111 [(-)-cis-1-methyl-7-[[4-(2,6-dichlorophenyl)piperidin-1-yl]methyl]-6,7,8 ,9-tetrahydro-5H-benzocyclohepten-5-ol]: In vivo studies 92
In vitro and in vivo pharmacological characterization of nociceptin/orphanin FQ tetrabranched derivatives 91
Further studies on nociceptin/orphanin FQ related peptides: discovery of a new chemical template with antagonist activity on the OP4 receptor. 90
Characterization of the human vascular kinin B2 receptor by binding assays. 90
In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist 88
null 87
Neuropeptide S is a stimulatory anxiolytic agent: A behavioural study in mice 86
Structure-activity studies on neuropeptide S - Identification of the amino acid residues crucial for receptor activation 84
null 84
Effects of Ro 64-6198 it nociceptin/orphanin FQ-sensitive isolated tissues 84
In vitro characterization of FR 190997, the first non peptide B2 receptor agonist receptor binding and bioassay in the human umbilical vein 82
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes. 79
null 79
Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad? 77
In vitro and in vivo pharmacological characterization of the neuropeptide S receptor antagonist [D-Cys(tBu)5]NPS. 77
Receptor binding profile of novel nociceptin/orphanin FQ receptor ligands in mouse brain membranes 76
MEN 11270, a novel selective constrained peptide antagonist with high affinity at the human B-2 kinin receptor 71
Further studies on nociceptin related peptides: discovery of new molecules with antagonist activity on the nociceptin receptor 68
Pharmacological characterization of the nociceptin receptors in the mouse: receptor binding, bioassay and behavioral studies 64
Totale 11.175
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.994
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.994
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.511 0 0 0 0 0 313 245 275 231 241 133 73
2020/20211.470 136 152 60 205 75 160 46 178 31 171 188 68
2021/20221.209 45 117 98 81 65 48 64 80 50 104 112 345
2022/20231.252 119 58 58 162 211 169 97 106 162 5 61 44
2023/2024646 73 82 30 16 35 131 24 57 9 12 21 156
2024/20251.050 67 70 209 108 326 270 0 0 0 0 0 0
Totale 11.799